Literature DB >> 7959478

Mefloquine distribution in postmortem cases.

R Jones1, G Kunsman, B Levine, M Smith, C Stahl.   

Abstract

Mefloquine is currently the drug-of-choice for malaria prophylaxis among military personnel. Four active duty military personnel receiving 250 mg mefloquine per week were killed in the line of duty under combat conditions. Samples of blood, bile, liver, kidney, muscle, brain, spleen and lung were submitted to the Division of Forensic Toxicology, Office of the Armed Forces Medical Examiner, for routine toxicologic analysis. Qualitative screening revealed only the presence of ethanol (< 25 mg/dl, probably attributable to postmortem formation) and mefloquine. Quantitation of mefloquine was performed using an HP 5880 gas chromatograph equipped with a nitrogen/phosphorus detector. The column was an HP-5 cross-linked 5% phenyl methyl silicone fused silica capillary column (15 m x 0.25 mm i.d. x 0.25 microns film thickness). The temperature program began at 110 degrees C, was held for 1 min and ramped at 20 degrees C/min to 200 degrees C, held for 1 min and then ramped at 10 degrees C/min to 280 degrees C and held for 10 min. Mefloquine elutes with a relative retention time similar to that of the tricyclic antidepressants. No postmortem data concerning mefloquine concentrations or tissue distribution was available. Quantitated blood concentrations in the presented cases were greater than the expected therapeutic values indicating the possibility of postmortem redistribution of this drug. No mefloquine overdoses were identified in the literature making comparison to the postmortem therapeutic concentrations impossible at this time.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959478     DOI: 10.1016/0379-0738(94)90376-x

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  16 in total

1.  Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro.

Authors:  Aaron Janowsky; Amy J Eshleman; Robert A Johnson; Katherine M Wolfrum; David J Hinrichs; Jongtae Yang; T Mark Zabriskie; Martin J Smilkstein; Michael K Riscoe
Journal:  Psychopharmacology (Berl)       Date:  2014-02-02       Impact factor: 4.530

Review 2.  Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.

Authors:  Leslie J Marshall; Eugene O Major
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-17       Impact factor: 4.147

Review 3.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

4.  Mefloquine-induced disruption of calcium homeostasis in mammalian cells is similar to that induced by ionomycin.

Authors:  D Caridha; D Yourick; M Cabezas; L Wolf; T H Hudson; G S Dow
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

5.  Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine.

Authors:  Peter Wipf; Tingting Mo; Steven J Geib; Diana Caridha; Geoffrey S Dow; Lucia Gerena; Norma Roncal; Erin E Milner
Journal:  Org Biomol Chem       Date:  2009-08-07       Impact factor: 3.876

6.  The antimalarial potential of 4-quinolinecarbinolamines may be limited due to neurotoxicity and cross-resistance in mefloquine-resistant Plasmodium falciparum strains.

Authors:  Geoffrey S Dow; Michael L Koenig; Lesley Wolf; Lucia Gerena; Miriam Lopez-Sanchez; Thomas H Hudson; Apurba K Bhattacharjee
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

7.  Use of mefloquine in multidrug-resistant Mycobacterium avium complex pulmonary disease in an HIV-negative patient.

Authors:  Juan Ramirez; Carol Mason; Juzar Ali
Journal:  Curr Ther Res Clin Exp       Date:  2007-11

8.  Identification and characterization of mefloquine efficacy against JC virus in vitro.

Authors:  Margot Brickelmaier; Alexey Lugovskoy; Ramya Kartikeyan; Marta M Reviriego-Mendoza; Norm Allaire; Kenneth Simon; Richard J Frisque; Leonid Gorelik
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

9.  Epileptogenic potential of mefloquine chemoprophylaxis: a pathogenic hypothesis.

Authors:  Remington L Nevin
Journal:  Malar J       Date:  2009-08-05       Impact factor: 2.979

10.  The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro.

Authors:  Geoffrey S Dow; Thomas H Hudson; Maryanne Vahey; Michael L Koenig
Journal:  Malar J       Date:  2003-06-12       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.